Ontogeny of muscarinic cholinergic supersensitivity in the flinders sensitive line rat

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 367-380

  Daws, Lynette C ^a   Overstreet, David H ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Core body temperature; Depression; FSL rats; Locomotor activity; Muscarinic receptors; Oxotremorine; Scopolamine

Indexed keywords

ATROPINE METHYL NITRATE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; OXOTREMORINE; SCOPOLAMINE; SCOPOLAMINE METHYL NITRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DEPRESSION; FEMALE; LOCOMOTION; MALE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SUBCUTANEOUS DRUG ADMINISTRATION; SUPERSENSITIVITY;

ANIMALS; BINDING SITES; BODY TEMPERATURE; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MOTOR ACTIVITY; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; OXOTREMORINE; QUINUCLIDINYL BENZILATE; RATS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; SCOPOLAMINE; VISUAL CORTEX;

EID: 0032910699     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00174-9     Document Type: Article

References (68)

1. Aubert I., Cecyra D., Gauthier S., Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. J. Comp. Neurol. 369:1996;31-55.
2. Baez L.A., Eskridge N.K., Schein R. Postnatal development of dopaminergic and cholinergic catelepsy in the rat. Eur. J. Pharmacol. 36:1976;155-162.
3. Balduini W., Murphy S.D., Costa L.G. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. J. Pharmacol. Exp. Ther. 241:1987;421-427.
4. Ben-Barak J., Dudai Y. Cholinergic binding sites in rat hippocampal formation. Properties and ontogenesis Brain Res. 166:1979;245-257.
5. Berger M., Riemann D., Hochli D., Speigel R. The cholinergic rapid eye movement sleep induction test with RS 86. Arch. Gen. Psychiatry. 46:1989;421-428.
6. Berger M., Riemann D., Kreig J.C. Cholinergic drugs as diagnostic and therapeutic tools in affective disorders. Acta Psychiatr. Scand. Suppl. 83:1991;52-60.
7. Bloszovski D., Bachevalier J. Effect of atropine on behavioral arousal in the developing rat. Dev. Psychobiol. 8:1975;97-102.
8. Bronstein P.M., Marcus M., Hirsch S.M. The ontogeny of locomotion in rats. The influence of ambient temperature Bull. Psychonom. Soc. 12:1978;39-42.
9. Butt A.M., Jones H.C., Abott N.J. Electrical resistance across the blood-brain barrier in anesthetized rats. A developmental study J. Physiol. 429:1990;47-62.
10. Campbell B.A., Lytle L.D., Fibiger H.C. Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science. 166:1969;635-637.
11. Campbell B.A., Mabry P.D. Ontogeny of behavioral arousal. A comparative study J. Comp. Physiol. Psychol. 81:1972;371-379.
12. Castellano C., Oliverio A., Schwab C., Bruckner G., Biesold D. Age-dependent differences in cholinergic drug responses in two strains of mice. Neurosci. Lett. 84:1988;335-338.
13. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
14. Collins A.C., Campbell S.M., Romm E., Marks M.J. A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice. Alcohol. Clin. Exp. Res. 14:1990;605-615.
15. Conklin P., Heggeness F.W. Maturation of temperature homeostasis in the rat. Am. J. Physiol. 220:1971;333-336.
16. Coyle J., Yamaura H. Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res. 118:1976;429-440.
17. Daws, L. C.: Ontogeny of muscarinic supersensitivity in the Flinders Sensitive Line rat - An animal model of depression. Dissertation, The Flinders University of South Australia; 1994.
18. Daws L.C., Schiller G.D., Overstreet D.H., Orbach J. Early development of muscarinic supersensitivity in a genetic animal model of depression. Neuropsychopharmacology. 4:1991;207-217.
19. DeLean A., Hancock A.A., Lefkowitz R.J. Validation and statistical analysis of a computer modelling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 21:1982;5-16.
20. De Vries T.J., Mulder A.H., Schoffelmeer A.N.M. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum. Dev. Brain Res. 66:1992;91-96.
21. Dohanich G.P., Witcher J.A., Weaver D.R., Clemens L.G. Alteration of muscarinic binding in specific brain areas following estrogen treatment. Brain Res. 241:1982;347-350.
22. Gershon E.S., Berrettini W., Nurnberger J.I. Jr., Goldin L.R. Genetics of affective illness. Meltzer H.Y. Psychopharmacology. The third generation of progress:1987;481-492 Raven Press, New York.
23. Hammer R., Berrie C.P., Birdsall A.S.V., Hulme E.C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 283:1980;90-92.
24. Hammer R., Giachetti A. Muscarinic receptor subtypes. M1 and M2 biochemical and functional characterization Life Sci. 7:1983;197-204.
25. Heacock A.M., Fisher S.K., Agranoff B.W. Enhance coupling of neonatal muscarinic receptors in rat brain to phosphoinositide turnover. J. Neurochem. 48:1991;1904-1911.
26. Innes, I. R.; Nickerson, M.: Atropine, scopolamine, and related antimuscarinic drugs. In: Goodman, L. S.; Gilman, A. eds. The pharmacological basis of therapeutics. New York: Macmillan; 1975:514-532.
27. Janowsky D.S., El-Yousef M.K., Davis J.M., Sekerke H. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. 2:1972;632-635.
28. Janowsky D.S., El-Yousef M.K., Davis J.M. Acetylcholine and depression. Psychosom. Med. 36:1974;248-257.
29. Janowsky D.S., Risch S.C. Acetycholine mechanisms in affective disorders. Meltzer H.Y. Psychopharmacology. The third generation of progress:1987;527-534 Raven Press, New York.
30. Janowsky D.S., Overstreet D.H., Nurnberger J.I. Jr. Is cholinergic sensitivity a genetic marker for the affective disorders. Am. J. Med. Genet. Neuropsychiatr. Genet. 54:1994;335-344.
31. Janowsky, D. S.; Overstreet, D. H.: The role of acetylcholine mechanisms in the affective disorders. In: Bloom, F. E.; Kupfer, D. J. eds. Psychopharmacology. The fourth generation of progress. New York: Raven Press; 1995:945-956.
32. Kaufman C., Gillin J.C., Hill B., O'Laughlin T., Phillips I., Gleinman J.B., Wyatt R.J. Muscarinic binding in suicides. Psychiatr. Res. 12:1984;47-56.
33. Kuhar M.J., Birdsall N.M.J., Burgen A.S.V., Hulme E.C. Ontogeny of muscarinic receptors in rat brain. Brain Res. 184:1980;375-383.
34. Kumar A., Schliebs R. Postnatal laminar development of cholinergic receptors, protein kinase C and dihydropyridine-sensitive calcium antagonist binding in rat visual cortex. Effect of visual deprivation. Int. J. Dev. Neurosci. 10:1992;491-504.
35. Lee W., Nicklaus K.J., Manning D.R., Wolfe B.B. Ontogeny of cortical muscarinic receptor subtypes and muscarinic mediated responses in the rat. J. Pharmacol. Exp. Ther. 252:1990;482-490.
36. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
37. Meyerson L.R., Wenogle L.P., Abel M.S., Cupet J., Lippa A.S., Rough C.E., Beer B. Human brain receptor alterations in suicide victims. Pharmacol. Biochem. Behav. 17:1982;159-163.
38. Miyoshi R., Kito S., Shimizu M., Matsubayashi H. Ontogeny of muscarinic receptors in the brain with emphasis on the differentiation of M1 and M2-subtypes. Semi-quantitative in vitro autoradiography Brain Res. 420:1987;302-312.
39. Nagy M.A., Murphy J.M., Ray D. Development of behavioral arousal and inhibition in the Swiss-Webster mouse. Bull. Psychonom. Soc. 6:1975;146-148.
40. Nurnberger J.I. Jr., Berrettini W., Mendelson W., Sack D., Gershon E.S. Measuring cholinergic sensitivity. I. Arecoline effects in bipolar patients Biol. Psychiatry. 25:1989;610-617.
41. Odagaki Y., Koyama T., Yamashita T. Platelet pertussis-toxin sensitive G proteins in affective disorders. J. Affect. Dis. 31:1994;173-177.
42. Overstreet D.H., Russell R.W., Helps S.C., Messenger M. Selective breeding for sensitivity to the anticholinesterase, DFP. Psychopharmacology (Berlin). 65:1979;15-20.
43. Overstreet D.H., Russell R.W. Selective breeding for sensitivity to DFP. Effects of cholinergic agonists and antagonists Psychopharmacology (Berlin). 78:1982;150-154.
44. Overstreet D.H., Russell R.W., Crocker A.D., Schiller G.D. Selective breeding for differences in cholinergic function. Pre- and post-synaptic mechanisms involved in sensitivity to the anticholinesterase, DFP Brain Res. 294:1984;327-332.
45. Overstreet D.H., Russell R.W., Crocker A.D., Gillin J.C., Janowsky D.S. Genetic and pharmacological models of cholinergic supersensitivity and affective disorders. Experientia. 44:1988;465-472.
46. Overstreet D.H. The Flinders Sensitive Line rats. A genetic animals model of depression Neurosci. Behav. Rev. 17:1993;51-68.
47. Overstreet D.H., Janowsky D.S., Pucilowski O., Rezvani A.H. Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in cross breeds of Flinders Line rats. Psychiatr. Genet. 4:1994;101-107.
48. Overstreet D.H., Pucilowski O., Rezvani A.H., Janowsky D.S. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berlin). 121:1995;27-37.
49. Overstreet, D. H.; Yang, Y.; Hamedi, M.; Janowsky, D. S.; Rezvani, A. H.: Strain- and gender-dependent effects of oxotremorine and pyridostigmine. Soc. Neurosci. Abstr. 23:1875; 1997.
50. Ozawa H., Gsell W., Frolich L., Zochlig R., Pantucek F., Beckmann H., Riederer P. Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients. J. Neural Transm. 94:1993;63-69.
51. Pepe S., Overstreet D.H., Crocker A.D. Enhanced benzodiazepine responsiveness in rats with increased cholinergic function. Pharmacol. Biochem. Behav. 31:1988;15-20.
52. Rainbow T.C., Snyder L., Berck D.J., McEwen B.S. Correlation of muscarinic receptor induction in the ventromedial hypothalamic nucleus with the activation of feminine sexual behavior by estradiol. Neuroendocrinology. 39:1984;476-480.
53. Resul B., Ringdahl B., Dahlbom R., Jenden D. Muscarinic activity of some secondary and tertiary amines and their quaternary ammonium salts structurally related to oxotremorine. Mol. Pharmacol. 23:1983;17-25.
54. Risau W., Wolburg H. Development of the blood-brain barrier. Trends Neurosci. 13:1990;174-178.
55. Risch S.C., Kalin N.H., Janowsky D.S. Cholinergic challenge in affective illness. Behavioral and neuroendocrine correlates J. Clin. Psychopharmacol. 1:1981;186-192.
56. Rooney T.A., Nahorski S.R. Postnatal ontogeny of agonist and depolarization-induced phosphoinositide hydrolysis in rat cerebral cortex. J. Pharmacol. Exp. Ther. 243:1987;333-341.
57. Russell R.W., Overstreet D.H., Messenger M., Helps S.C. Selective breeding for sensitivity to DFP. Generalization of effects beyond criterion variables Pharmacol. Biochem. Behav. 17:1982;885-891.
58. Schanker L.S. Passage of drugs across body membranes. Pharmacol. Rev. 14:1962;501-530.
59. Schiller G.D., Pucilowski O., Wienicke C., Overstreet D.H. Immobility-reducing effects of antidepressants in a genetic animal model of depression. Brain Res. Bull. 28:1992;821-823.
60. Schreiber W., Lauer C.J., Klumrey F.H., Kreig J.C. Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders. Biol. Psychiatry. 32:1992;79-90.
61. Schulz C., Firth A.J. Interendothelial junctions during blood-brain-barrier development in the rat. Morphological changes at the level of individual tight junctional contacts Dev. Brain Res. 69:1992;85-95.
62. Sitaram N., Jones D., Dube S., Keshavan M., Bell J., Davies A., Reynal P. The association of supersensitive cholinergic REM-induction and affective illness within pedigrees. J. Psychiatr. Res. 21:1987;487-497.
63. Stanley M. Cholinergic receptor binding in the frontal cortex of suicide victims. Am. J. Psychiatry. 141:1984;1432-1436.
64. Vernadakis A., Woodbury D.M. The developing animal as a model. Epilepsia. 10:1969;163-178.
65. Wall S.J., Yasuda R.P., Li M., Ciesla W., Wolfe B.B. The ontogeny of m1-m5 muscarinic receptor subtypes in rat forebrain. Dev. Brain Res. 66:1992;181-185.
66. 3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 receptor subtypes. Life Sci. 32:1983;3001-3011.
67. Webb D.R., McClure P.A. Development of heat production in atricial and precocial rodents. Implications for the energy allocation hypothesis Physiol. Zool. 62:1989;1293-1315.
68. Zahalka E.A., Seidler F.J., Lappi S.E., Yanai J., Slotkin T.A. Differential development of cholinergic nerve terminal markers in rat brain regions. Implications for nerve terminal density, impulse activity and specific gene expression Brain Res. 601:1993;221-229.